Your browser doesn't support javascript.
loading
A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.
Carlozzi, Noelle E; Hahn, E A; Frank, S A; Perlmutter, J S; Downing, N D; McCormack, M K; Barton, S; Nance, M A; Schilling, S G.
Afiliação
  • Carlozzi NE; Department of Physical Medicine and Rehabilitation, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building NCRC B14, Room G216, Ann Arbor, MI, 48109-2800, USA. carlozzi@med.umich.edu.
  • Hahn EA; Department of Medical Social Sciences, Northwestern University, Chicago, IL, USA.
  • Frank SA; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Perlmutter JS; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
  • Downing ND; Departments of Radiology and Neuroscience, Program in Occupational Therapy and Program in Physical Therapy, Washington University, St. Louis, MO, USA.
  • McCormack MK; Forensic Health Care College of Nursing, Texas A&M University, College Station, TX, USA.
  • Barton S; Department of Psychiatry, Rutgers University-Robert Wood Johnson Medical School, Brunswick, NJ, USA.
  • Nance MA; Piscataway and Department of Pathology, Rowan University-SOM, Stratford, NJ, USA.
  • Schilling SG; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
J Neurol ; 265(1): 98-107, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29143208
ABSTRACT

BACKGROUND:

Huntington disease is a fatal inherited neurodegenerative disease. Because the end result of Huntington disease is death due to Huntington disease-related causes, there is a need for better understanding and caring for individuals at their end of life.

AIM:

The purpose of this study was to develop a new measure to evaluate end of life planning.

DESIGN:

We conducted qualitative focus groups, solicited expert input, and completed a literature review to develop a 16-item measure to evaluate important aspects of end of life planning for Huntington disease. Item response theory and differential item functioning analyses were utilized to examine the psychometric properties of items; exploratory factor analysis was used to establish meaningful subscales.

PARTICIPANTS:

Participants included 508 individuals with pre-manifest or manifest Huntington disease.

RESULTS:

Item response theory supported the retention of all 16 items on the huntington disease quality of life ("HDQLIFE") end of life planning measure. Exploratory factor analysis supported a four-factor structure legal planning, financial planning, preferences for hospice care, and preferences for conditions (locations, surroundings, etc.) at the time of death. Although a handful of items exhibited some evidence of differential item functioning, these items were retained due to their relevant clinical content. The final 16-item scale includes an overall total score and four subscale scores that reflect the different end of life planning constructs.

CONCLUSIONS:

The 16-item HDQLIFE end of life planning measure demonstrates adequate psychometric properties; it may be a useful tool for clinicians to clarify patients' preferences about end of life care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Assistência Terminal / Doença de Huntington Tipo de estudo: Qualitative_research Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Assistência Terminal / Doença de Huntington Tipo de estudo: Qualitative_research Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Ano de publicação: 2018 Tipo de documento: Article